======= COMMD3-BMI1 =======
== Gene Information ==
* **Official Symbol**: N/A
* **Official Name**: N/A
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: N/A
* **UniProt**: N/A
* **Interactions**: [[https://thebiogrid.org/search.php?search=COMMD3-BMI1&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20COMMD3-BMI1|Open PubMed]]
* **OMIM**: N/A
== Function Summary ==
* **Entrez Summary**: N/A
* **UniProt Summary**: Component of a Polycomb group (PcG) multiprotein PRC1- like complex, a complex class required to maintain the transcriptionally repressive state of many genes, including Hox genes, throughout development. PcG PRC1 complex acts via chromatin remodeling and modification of histones; it mediates monoubiquitination of histone H2A 'Lys-119', rendering chromatin heritably changed in its expressibility (PubMed:15386022, PubMed:16359901, PubMed:26151332, PubMed:16714294, PubMed:21772249, PubMed:25355358, PubMed:27827373). The complex composed of RNF2, UB2D3 and BMI1 binds nucleosomes, and has activity only with nucleosomal histone H2A (PubMed:21772249, PubMed:25355358). In the PRC1-like complex, regulates the E3 ubiquitin-protein ligase activity of RNF2/RING2 (PubMed:15386022, PubMed:26151332, PubMed:21772249). {ECO:0000269|PubMed:15386022, ECO:0000269|PubMed:16359901, ECO:0000269|PubMed:16714294, ECO:0000269|PubMed:16882984, ECO:0000269|PubMed:21772249, ECO:0000269|PubMed:25355358, ECO:0000269|PubMed:26151332, ECO:0000269|PubMed:27827373}.
|zf-C3HC4|
|HCaRG|
|histone H2A-K119 monoubiquitination|
|PRC1 complex|
|histone H2A monoubiquitination|
|histone H2A ubiquitination|
|histone monoubiquitination|
|histone ubiquitination|
|promoter-specific chromatin binding|
|chromatin organization involved in negative regulation of transcription|
|chromatin silencing|
|protein monoubiquitination|
|chromatin organization involved in regulation of transcription|
|negative regulation of gene expression, epigenetic|
|gene silencing|
|regulation of gene expression, epigenetic|
|histone modification|
|covalent chromatin modification|
|protein ubiquitination|
|chromatin organization|
|protein modification by small protein conjugation|
|negative regulation of transcription by RNA polymerase II|
|protein modification by small protein conjugation or removal|
|chromosome organization|
|negative regulation of transcription, DNA-templated|
|negative regulation of nucleic acid-templated transcription|
|negative regulation of RNA biosynthetic process|
|negative regulation of RNA metabolic process|
|negative regulation of cellular macromolecule biosynthetic process|
|negative regulation of nucleobase-containing compound metabolic process|
|negative regulation of macromolecule biosynthetic process|
|negative regulation of cellular biosynthetic process|
|negative regulation of biosynthetic process|
|negative regulation of gene expression|
\\
=== CRISPR Data ===
^Screen^Score^
|[[:results:exp89|Vemurafenib 6.6μM R02 exp89]]|-2.16|
|[[:results:exp432|YM155 0.001μM R08 exp432]]|-2.02|
|[[:results:exp454|Bafilomycin-A1 0.009μM R08 exp454]]|-1.74|
|[[:results:exp470|Chloroquine 32μM R08 exp470]]|-1.71|
|[[:results:exp153|SGC2096 2.6μM R03 exp153]]|1.73|
|[[:results:exp264|Arsenate 40μM R06 exp264]]|1.9|
No correlation found to any other genes in chemogenomics.
Global Fraction of Cell Lines Where Essential: N/A
^Tissue^Fraction Of Cell Lines Where Essential^
== Essentiality in NALM6 ==
* **Essentiality Rank**: 7479
* **Expression level (log2 read counts)**: 4.12
{{:chemogenomics:nalm6 dist.png?nolink |}}